Vor Biopharma, Inc. (VOR)
18.03
-1.31
(-6.77%)
USD |
NASDAQ |
Oct 16, 16:00
17.73
-0.30
(-1.66%)
After-Hours: 20:00
Vor Biopharma Max Drawdown (5Y) : 99.72% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.72% |
| August 31, 2026 | 99.72% |
| July 31, 2026 | 99.72% |
| June 30, 2026 | 99.72% |
| May 31, 2026 | 99.72% |
| April 30, 2026 | 99.72% |
| March 31, 2026 | 99.72% |
| February 28, 2026 | 99.72% |
| January 31, 2026 | 99.72% |
| December 31, 2025 | 99.72% |
| November 30, 2025 | 99.72% |
| October 31, 2025 | 99.72% |
| September 30, 2025 | 99.72% |
| August 31, 2025 | 99.72% |
| July 31, 2025 | 99.72% |
| June 30, 2025 | 99.72% |
| May 31, 2025 | 99.72% |
| April 30, 2025 | 98.99% |
| March 31, 2025 | 98.82% |
| February 28, 2025 | 98.82% |
| January 31, 2025 | 98.82% |
| December 31, 2024 | 98.82% |
| November 30, 2024 | 98.82% |
| October 31, 2024 | 98.82% |
| September 30, 2024 | 98.71% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.52% |
| July 31, 2024 | 98.32% |
| June 30, 2024 | 98.15% |
| May 31, 2024 | 97.52% |
| April 30, 2024 | 96.94% |
| March 31, 2024 | 96.94% |
| February 29, 2024 | 96.94% |
| January 31, 2024 | 96.94% |
| December 31, 2023 | 96.94% |
| November 30, 2023 | 96.94% |
| October 31, 2023 | 96.62% |
| September 30, 2023 | 96.12% |
| August 31, 2023 | 95.38% |
| July 31, 2023 | 94.91% |
| June 30, 2023 | 94.29% |
| May 31, 2023 | 93.04% |
| April 30, 2023 | 93.04% |
| March 31, 2023 | 93.04% |
| February 28, 2023 | 93.04% |
| January 31, 2023 | 93.04% |
| December 31, 2022 | 93.04% |
| November 30, 2022 | 93.04% |
| October 31, 2022 | 93.04% |
| September 30, 2022 | 92.81% |
| August 31, 2022 | 92.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agenus, Inc. | 98.84% |
| Amgen, Inc. | 24.86% |
| Anika Therapeutics, Inc. | 83.15% |
| BioCryst Pharmaceuticals, Inc. | 79.10% |
| Imunon, Inc. | 99.49% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -64.48 |
| Beta (5Y) | 1.781 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 385.3% |
| Historical Sharpe Ratio (5Y) | -0.1211 |
| Historical Sortino (5Y) | -0.8257 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.80% |